Update on paraneoplastic syndromes
- 1 June 2005
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Neurology
- Vol. 18 (3), 331-336
- https://doi.org/10.1097/01.wco.0000169754.38944.a4
Abstract
This review discusses the varied clinical spectrum of neurologic paraneoplastic disorders, describes recent advances in our understanding of autoimmunity in these disorders, and outlines a practical clinical approach to patient management. Paraneoplastic disorders may affect any part of the central or peripheral nervous system. Although relatively uncommon, these disorders are a significant cause of severe and permanent neurologic disability. Syndromes such as limbic encephalitis or opsoclonus-myoclonus should always raise suspicion of a paraneoplastic condition, but any paraneoplastic syndrome can also occur in patients without a neoplasm. Most neurologic paraneoplastic disorders are thought to be caused by an autoimmune reaction directed against ‘onconeural’ antigens expressed by neurons and tumor cells. Some syndromes such as Lambert–Eaton myasthenic syndrome and neuromyotonia are clearly mediated by autoantibodies. Much less is known about the immunopathogenesis of syndromes that affect the central nervous system, although a growing body of evidence implicates cellular immune effectors in causing neuronal injury. Many patients have circulating antineuronal antibodies, which can be useful in identifying a neurologic disorder as paraneoplastic and in finding the associated neoplasm. Early diagnosis of the neurologic disorder and prompt initiation of tumor treatment probably increase the likelihood of neurologic improvement. Neurologists must be able to recognize the clinical manifestations of neurologic paraneoplastic disorders, and to distinguish them from other causes of neurologic dysfunction in cancer patients. Early diagnosis of paraneoplastic syndromes maximizes the likelihood of a favorable oncologic and neurologic outcome.Keywords
This publication has 49 references indexed in Scilit:
- Autoantibody Profiles and Neurological Correlations of ThymomaClinical Cancer Research, 2004
- Neurologic disorders in 432 consecutive patients with small cell lung carcinomaCancer, 2004
- Clinical, Magnetic Resonance Imaging, and Electroencephalographic Findings in Paraneoplastic Limbic EncephalitisMayo Clinic Proceedings, 2003
- Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patientsBrain, 2003
- Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic CancerMedicine, 2003
- Screening for autoantibodies in children with opsoclonus-myoclonus-ataxiaPediatric Neurology, 2002
- Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathyZeitschrift für Neurologie, 2002
- Remote Neurologic Manifestations of CancerNeurologic Clinics, 2002
- Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patientsBrain, 2001
- Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patientsBrain, 2000